Medipharm is a finished-dose manufacturer based in Tunisia. It appears in 64 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with ISP (CL), HSA (SG) and MCAZ (ZW). Its GMP standing is certified by HSA (SG).
| Regulator | Filings | GMP certificates |
|---|---|---|
| ISP (CL) | 57 | None |
| HSA (SG) | 6 | 3 |
| MCAZ (ZW) | 1 | None |
Beyond the filing counts above, the public registers hold no plant, inspection or portfolio detail for this company as at 9 July 2026. We report that as a gap rather than inferring an answer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Medipharm comes back tiered against every other supplier able to file there.
Start for free